Skip to main content
. 2019 Jan 3;10(2):256–267. doi: 10.1111/1759-7714.12945

Figure 5.

Figure 5

Nomograms of the results of prognostic models using clinicopathological characteristics and pretreatment inflammatory biomarkers to predict (a) overall survival (OS) and (b) recurrence‐free survival (RFS) of patients with lung adenocarcinoma. Nomograms can be interpreted by summing up the points assigned to each variable, indicated at the top of the scale. The total points can be converted to predict the five‐year probability of death and recurrence or metastasis for a patient in the lowest scale. Harrell's c‐indexes for OS and RFS prediction were 0.84 (95% confidence interval [CI] 0.76–0.91) and 0.82 (95% CI 0.76–0.89), respectively. Calibration curves for five‐year (c) OS and (d) RFS using nomograms with clinicopathological characteristics and pretreatment inflammatory biomarkers are shown. The x‐axis represents the nomogram‐predicted probability of survival and the y‐axis represents actual survival. The reference line is 45°and indicates perfect calibration. SMA, smooth muscle actin; STAS, spread through air space.